Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   Inhibition of Plasmodium falciparum plasmepsins by drugs targeting HIV-1 protease: A way forward for antimalarial drug discovery
  2. Mishra, Vandana; Deshmukh, Anuradha; Rathore, Ishan; Chakraborty, Satadru; Patankar, Swati; Gustchina,Alla; Wlodawer,Alexander; Yada, Rickey Y; Bhaumik, Prasenjit
  3. Current Research in Structural Biology. 2024, Jan 17; 7: 100128.
  1. 2.   Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment
  2. Epling, Brian P; Rocco, Joseph M; Boswell, Kristin L; Laidlaw, Elizabeth; Galindo, Frances; Kellogg,Anela; Das, Sanchita; Roder, Allison; Ghedin, Elodie; Kreitman, Allie; Dewar,Robin; Kelly, Sophie E M; Kalish, Heather; Rehman, Tauseef; Highbarger,Jeroen; Rupert,Adam; Kocher, Gregory; Holbrook, Michael R; Lisco, Andrea; Manion, Maura; Koup, Richard A; Sereti, Irini
  3. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2022, Oct 06;
  1. 3.   Utilization of Direct Oral Anticoagulants in People with HIV: Observational Data from the DC Cohort
  2. George, Jomy M; Kuriakose,Safia; Monroe, Anne; Hou, Qingjiang; Byrne, Morgan; Pau, Alice K; Masur, Henry; Hadigan, Colleen; Castel, Amanda D; Horberg, Michael A
  3. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020, Dec 17; 71(10): E604-E613.
  1. 4.   Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of Dabigatran
  2. Kumar, Parag; Gordon, Lori A.; Brooks, Kristina M.; George, Jomy M.; Kellogg, Anela; McManus, Maryellen; Alfaro, Raul M.; Nghiem, Khanh; Lozier, Jay; Hadigan, Colleen; Penzak, Scott R.
  3. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2017, NOV; 61(11):
  1. 5.   Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy
  2. McKinnon, J. E.; Delgado, R.; Pulido, F.; Shao, W.; Arribas, J. R.; Mellors, J. W.
  3. Antiviral Therapy. 2011 16(5): 725-732.
  1. 6.   Recognition and Management of Significant Drug Interactions in HIV Patients: Challenges in Using Available Data to Guide Therapy
  2. Pau, A. K.; Boyd, S. D.
  3. Clinical Pharmacology & Therapeutics. 2010, Nov; 88(5): 712-719.
  1. 7.   Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48-Week Clinical and Virologic Outcomes
  2. Wilkin, T. J.; McKinnon, J. E.; DiRienzo, A. G.; Mollan, K.; Fletcher, C. V.; Margolis, D. M.; Bastow, B.; Thal, G.; Woodward, W.; Godfrey, C.; Wiegand, A.; Maldarelli, F.; Palmer, S.; Coffin, J. M.; Mellors, J. W.; Swindells, S.
  3. Journal of Infectious Diseases. 2009 199(6): 866-871.
  1. 8.   Lack of sex-related differences in saquinavir pharmacokinetics in an HIV-seronegative cohort
  2. Robertson, S. M.; Formentini, E.; Alfaro, R. M.; Natarajan, V.; Falloon, J.; Penzak, S. R.
  3. British Journal of Clinical Pharmacology. 2006, Apr; 61(4): 379-388.
  1. 9.   Prednisolone pharmacokinetics in the presence and absence of Ritonavir after oral prednisone administration to healthy volunteers
  2. Penzak, S. R.; Fomnentini, E.; Alfaro, R. M.; Long, M.; Natarajan, V.; Kovacs, J.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 15; 40(5): 573-580.
  1. 10.   Ritonavir decreases the nonrenal clearance of digoxin in healthy volunteers with known MDR1 genotypes
  2. Penzak, S. R.; Shen, J. M.; Alfaro, R. M.; Remaley, A. T.; Natarajan, V.; Falloon, J.
  3. Therapeutic Drug Monitoring. 2004 26(3): 322-330.
  1. 11.   Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy
  2. Nijhuis, M.; Schuurman, R.; de Jong, D.; Erickson, J.; Gustchina, E.; Albert, J.; Schipper, P.; Gulnik, S.; Boucher, C. A. B.
  3. Aids. 1999 13(17): 2349-2359.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel